This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- München, DE (2020)
- Munich, DE (2022)
Company Filing History:
2 out of 159 
2 out of 64 
1 out of 168 
Years Active: 2020-2025
Title: The Innovative Contributions of Ottheinz Krebs
Introduction
Ottheinz Krebs is a notable inventor based in Munich, Germany. He has made significant contributions to the field of virology, particularly in the development of parvovirus-based therapies. With a total of 3 patents, his work has the potential to impact cancer treatment and viral production.
Latest Patents
Krebs' latest patents include groundbreaking inventions aimed at optimizing parvovirus production and formulation. One of his patents, titled "Optimized parvovirus H-1 production," provides a robust single clone Master Cell Bank (MCB) for enhanced production of H-1 parvovirus. This innovation is designed to increase infectious parvovirus production compared to standard producer NB-324K mixed cells. Another significant patent is the "Parvovirus formulation for treating tumors," which describes a formulation comprising parvovirus H-1 and a pharmaceutically acceptable carrier. This formulation is particularly aimed at the therapy of brain tumors through intratumoral injection.
Career Highlights
Throughout his career, Krebs has worked with esteemed institutions such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Ruprecht-Karls-University Heidelberg. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Krebs has collaborated with notable colleagues, including Barbara Leuchs and Jean Rommelaere. These partnerships have further enriched his research and innovations in the field of virology.
Conclusion
Ottheinz Krebs is a distinguished inventor whose work in parvovirus research holds promise for future therapeutic applications. His patents reflect a commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile